Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,171) with videos related to
Page
of 118
Sort By:
Pain
|
October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations
Alec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
JAMA Network Open
|
October 21, 2024
Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial
Bridget Freisthler, Rouba A Chahine, Jennifer Villani, et al.
Pain
|
September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
Sandra D Comer, James P Zacny, Robert H Dworkin, et al.
AJPM Focus
|
October 2, 2025
Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?
Frances R Levin, Douglas R Oyler, Denise C Babineau, et al.
Plos One
|
December 4, 2024
Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention
Nicky Lewis, Barry Eggleston, Redonna K Chandler, et al.
American Journal of Public Health
|
October 10, 2024
Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial
Patricia R Freeman, Alexander Y Walley, T John Winhusen, et al.
The International Journal on Drug Policy
|
April 12, 2025
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial
Louisa Gilbert, Rouba Chahine, Redonna Chandler, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Drug and Alcohol Dependence
|
July 20, 2025
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial
Jennifer L Brown, Marc R Larochelle, Laura C Fanucchi, et al.
Page
of 118
Search research articles
Search
Showing results (1161-1170 of 1,171) with videos related to
Sort By:
Page
of 118
Pain
|
October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations
Alec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
JAMA Network Open
|
October 21, 2024
Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial
Bridget Freisthler, Rouba A Chahine, Jennifer Villani, et al.
Pain
|
September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
Sandra D Comer, James P Zacny, Robert H Dworkin, et al.
AJPM Focus
|
October 2, 2025
Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?
Frances R Levin, Douglas R Oyler, Denise C Babineau, et al.
Plos One
|
December 4, 2024
Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention
Nicky Lewis, Barry Eggleston, Redonna K Chandler, et al.
American Journal of Public Health
|
October 10, 2024
Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial
Patricia R Freeman, Alexander Y Walley, T John Winhusen, et al.
The International Journal on Drug Policy
|
April 12, 2025
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial
Louisa Gilbert, Rouba Chahine, Redonna Chandler, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Drug and Alcohol Dependence
|
July 20, 2025
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial
Jennifer L Brown, Marc R Larochelle, Laura C Fanucchi, et al.
Page
of 118